agilon health (NYSE:AGL) Stock Price Up 8.5% After Analyst Upgrade

Shares of agilon health, inc. (NYSE:AGL) shot up 8.5% during trading on Thursday after Sanford C. Bernstein raised their price target on the stock from $2.50 to $3.15. Sanford C. Bernstein currently has a market perform rating on the stock. agilon health traded as high as $3.07 and last traded at $3.06. 2,185,717 shares changed hands during trading, a decline of 49% from the average session volume of 4,326,648 shares. The stock had previously closed at $2.82.

Other analysts also recently issued reports about the company. Bank of America downgraded agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a report on Wednesday, October 2nd. Citigroup upgraded agilon health from a “sell” rating to a “neutral” rating and increased their price target for the company from $1.75 to $2.25 in a report on Friday, January 10th. Evercore ISI lowered their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a report on Tuesday, October 8th. William Blair downgraded agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $3.00 price target on shares of agilon health in a report on Tuesday, November 19th. Two investment analysts have rated the stock with a sell rating, fourteen have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, agilon health has a consensus rating of “Hold” and an average price target of $4.03.

Insider Buying and Selling at agilon health

In related news, Director John William Wulf purchased 45,000 shares of agilon health stock in a transaction dated Thursday, December 5th. The shares were acquired at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the transaction, the director now owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Karen Mcloughlin purchased 25,000 shares of agilon health stock in a transaction dated Friday, December 13th. The shares were bought at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the transaction, the director now directly owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. The trade was a 51.90 % increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 90,000 shares of company stock valued at $198,100 in the last ninety days. Insiders own 3.20% of the company’s stock.

Hedge Funds Weigh In On agilon health

Large investors have recently modified their holdings of the stock. Oak Thistle LLC bought a new position in shares of agilon health during the fourth quarter worth about $25,000. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of agilon health during the third quarter worth about $28,000. Pines Wealth Management LLC bought a new position in agilon health in the fourth quarter worth about $51,000. City State Bank bought a new position in agilon health in the third quarter worth about $52,000. Finally, Aigen Investment Management LP bought a new position in agilon health in the third quarter worth about $79,000.

agilon health Stock Up 5.1 %

The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. The stock’s fifty day simple moving average is $2.07 and its 200-day simple moving average is $3.67. The stock has a market cap of $1.22 billion, a P/E ratio of -3.15 and a beta of 0.53.

agilon health (NYSE:AGL) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same period in the prior year, the business earned ($0.06) EPS. On average, research analysts anticipate that agilon health, inc. will post -0.59 earnings per share for the current year.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.